Innovations in Cellulite Treatment: Dissolving Barriers for Optimal Outcomes


Release Date: February 15, 2021
Last Reviewed: January 27, 2021
Expiration Date: February 15, 2022
Time to Complete Activity: 1.5 hours 


Steering Committee and Faculty
Julius Few, MD, Chair

Director and Founder
The Few Institute for Aesthetic Plastic Surgery
Clinical Professor of Surgery
Division of Plastic Surgery
University of Chicago Pritzker School of Medicine
Health Systems Clinician
Northwestern Memorial Hospital
Chicago, IL

Sabrina G. Fabi, MD, FAAD, FAACS
Volunteer Assistant Clinical Professor
Department of Medicine/Dermatology
University of California, San Diego
Goldman Butterwick Fitzpatrick Groff and Fabi Cosmetic Laser Dermatology
San Diego, CA

Joely Kaufman, MD
Skin Associates of South Florida and Skin Research Institute
Coral Gables, FL
Voluntary Associate Professor of Dermatology
University of Miami Miller School of Medicine
Miami, FL

Deanne Mraz Robinson, MD, FAAD
President and Co-Founder
Modern Dermatology
Westport, CT
Assistant Clinical Professor of Dermatology
Yale New Haven Hospital
New Haven, CT

Sachin M. Shridharani, MD, FACS
Director and Founder
LUXURGERY
New York, NY
This activity is provided by Paradigm Medical Communications, LLC.    

Disclosure of Commercial Support
This activity is supported by an educational grant from Endo Pharmaceuticals Inc.

This activity is supported with in-kind contributions:
Endo Pharmaceuticals Inc. – disposable supplies (vials)

Target Audience
This activity has been designed to address the educational needs of dermatologists, plastic surgeons, facial plastic surgeons, dermatologic surgeons, cosmetic surgeons, nurse practitioners (NPs), and PAs. It may also be of benefit to other physicians, nurses, and healthcare providers who are involved in the field of aesthetic medicine.

Statement of Need
Nonsurgical aesthetic therapy for cellulite, an undesirable condition that can be psychosocially debilitating for many women, has undergone tremendous growth and change, with new and emerging treatments that improve the appearance of cellulite. To make appropriate treatment recommendations, aesthetic clinicians need first to perform proper pretreatment assessment based on a thorough knowledge of cellulite anatomy and pathophysiology. The emergence of promising new nonsurgical therapies for cellulite presents a challenge for aesthetic clinicians, who need to be aware of the data and mechanisms of action (MOA) to meaningfully incorporate these options in their clinical practice. This activity is designed and guided by national experts in aesthetic medicine to help aesthetic clinicians optimally integrate novel and emerging therapies for cellulite into practice to provide improved outcomes and quality of life for their patients.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Review the anatomy and pathophysiology of cellulite formation as they relate to pretreatment assessment for individualized aesthetic therapy
  • Evaluate clinical evidence and mechanism of action for current and emerging nonsurgical therapies for managing cellulite
  • Formulate optimal nonsurgical treatment strategies, alone and in combination, for managing cellulite

Physician Accreditation Statement
Paradigm Medical Communications, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation Statement
Paradigm Medical Communications, LLC designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

PA Continuing Education
PAs may claim a maximum of 1.5 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

Nurse Practitioner Continuing Education
The American Academy of Nurse Practitioners Certification Program (AANPCP) accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with the AANPCP for further guidelines.

Instructions for Participation 
To receive a CME certificate of participation, you should:

  • Follow instructions to register or log in with your professional information and complete the pre-activity assessment
  • View the online activity in its entirety
  • Complete and submit the online posttest and evaluation. You must answer 70% of the posttest questions correctly to earn credit. You will have unlimited opportunities to successfully complete the posttest

A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.

For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949 or cme@paradigmmc.com.

There is no fee required for participation in this activity.

Hardware/Software Requirements
This certified CME activity is designed using HTML5 web components. As you navigate the video using the supplied controls, the slides will sync to the speaker.

Supported Browsers (Desktop/Mobile)
Chrome 45+, Firefox 40+, Edge, Edge Chromium, Safari 8+, Opera 31+

PDF documents
This activity may contain PDF documents. Most current browsers support viewing of PDFs natively, but you may also download a free version of Adobe Acrobat Reader here: http://get.adobe.com/reader

Technical Support: If you have any technical problems or playback issues email us at contactus@paradigmmc.com.

Disclosures
In accordance with ACCME requirements on disclosure, faculty and contributors are asked to disclose any relationships with commercial interests associated with the area of medicine featured in the activity. These relationships are described below. Any potential conflicts of interest have been resolved.

Julius Few, MD, Chair
Consulting Fees: Allergan, Inc.; BELLUS Health Inc.; Merz North America, Inc.; Sinclair Pharma; Venus Concept Inc.
Investigator: Allergan, Inc.; Sinclair Pharma; Venus Concept Inc.
Royalty: Thieme Medical Publishers, Inc.

Sabrina G. Fabi, MD, FAAD, FAACS
Consulting Fees: Allergan, Inc.; Endo Pharmaceuticals Inc.; Galderma Laboratories, L.P.; Merz North America, Inc.; Revance Therapeutics, Inc
Speakers Bureau: Allergan, Inc.; Merz North America, Inc.
Grant/Research Support: Allergan, Inc.; Endo Pharmaceuticals Inc.; Merz North America, Inc.; Revance Therapeutics, Inc
Stock Shareholder: Allergan, Inc.; Revance Therapeutics, Inc

Joely Kaufman, MD
Consulting Fees: Allergan, Inc.; Endo Pharmaceuticals Inc.; Galderma Laboratories, L.P.; Revance Therapeutics, Inc
Grant/Research Support: Allergan, Inc.; Croma-Pharma GmbH; Endo Pharmaceuticals Inc.; Galderma Laboratories, L.P.; Revance Therapeutics, Inc; Teoxane SA

Deanne Mraz Robinson, MD, FAAD
Consulting Fees: Alastin Skincare, Inc; ISDIN; PCA SKIN
Speakers Bureau: Allergan, Inc.; Cynosure, Inc; Galderma Laboratories, L.P.; Merz North America, Inc.
Grant/Research Support: Alastin Skincare, Inc; Galderma Laboratories, L.P.
Stock Shareholder: Alastin Skincare, Inc

Sachin M. Shridharani, MD, FACS
Consulting Fees: Allergan, Inc.; Endo Pharmaceuticals Inc.; Evolus, Inc.; Galderma Laboratories, L.P.; Prollenium Medical Technologies, Inc.; Sientra, Inc.; Sinclair Pharma
Speakers Bureau: Allergan, Inc.; Evolus, Inc.; Galderma Laboratories, L.P.; Prollenium Medical Technologies, Inc.; Sientra, Inc.
Grant/Research Support and Investigator: Allergan, Inc.; Endo Pharmaceuticals Inc.; Galderma Laboratories, L.P.; Prollenium Medical Technologies, Inc.; Sinclair Pharma

Paradigm Medical Communications, LLC staff members have no financial relationships to disclose.

Independent peer reviewer has no financial relationships to disclose.

Resolution of Conflict of Interest
Paradigm Medical Communications, LLC has implemented a system to resolve conflicts of interest for each CME activity to help ensure content is objective, fair and balanced, independent, and aligned with the public interest. Conflicts, if any, are resolved through one or more processes. All CME content in this activity was independently reviewed to ensure that it is free of commercial bias, scientifically rigorous, aligned with the public interest, and compliant with all regulatory guidance and the ACCME’s Standards for Commercial Support of Continuing Medical Education.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA.


Disclaimer
This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

If included, signed statements of informed consent granting permission for publication have been obtained for all photographs and videos in which an individual can be identified.

As an ACCME-accredited provider, Paradigm Medical Communications, LLC activities must include a balanced view of therapeutic options. Use of generic names contributes to this impartiality. The use of trade names should not be viewed as an endorsement of specific products by Paradigm Medical Communications, LLC. 

Terms of Use and Privacy Policy
Disclaimer
The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. This CME activity represents the views and opinions of the individual faculty, and does not constitute the opinion or endorsement of, or promotion by, Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Paradigm Medical Communications, LLC. Paradigm Medical Communications, LLC accepts no liability for the content referenced in this activity.

Privacy policy
Paradigm Medical Communications, LLC or hosted contracted partner is committed to protecting the privacy of those who participate in the activities located at www.paradigmmc.com (herein referred to as “website"). The information below describes the security of the website for safeguarding personal information and the rationale for collection and use of personal information.

Security/safeguarding personal information
This website has physical and procedural safeguards in place to prevent unauthorized access to personal information used to access this website.

Collection and use of your personal information
The submission of certain personally identifiable information is necessary to award and track the credits participants may earn after completing the program. Required items include first name, last name, degree, and email address. These items are necessary. Participants are also required to complete an evaluation of the CME activity. All evaluative information submitted is collected and retained, and used by Paradigm Medical Communications, LLC to continuously improve the learning experience.

Paradigm Medical Communications, LLC does not transfer, sell, or share personal information with outside parties. Paradigm Medical Communications, LLC will not otherwise disclose personal information unless required to in a legal process. Paradigm Medical Communications, LLC staff members review individual test results to the extent necessary to record and track participants’ credits.

Contact Us
If you have any questions or comments, please email us at contactus@paradigmmc.com 

© 2021 Paradigm Medical Communications, LLC except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.